SMTL ID : 7qk4.1

EED in complex with PRC2 allosteric inhibitor compound 22 (MAK683)

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.60 Å

Oligo State

hetero-1-1-mer

Ligands

3 x CL: CHLORIDE ION(Non-functional Binders)

CL.1: 4 residues within 4Å: Chain A: R.194, K.218, H.220, F.221 Ligand excluded by PLIP CL.2: 3 residues within 4Å: Chain A: Q.25, A.76, W.77 Ligand excluded by PLIP CL.3: 2 residues within 4Å: Chain A: H.230, E.250 Ligand excluded by PLIP

1 x EJR: N-[(5-fluoranyl-2,3-dihydro-1-benzofuran-4-yl)methyl]-8-(2-methylpyridin-3-yl)-[1,2,4]triazolo[4,3-c]pyrimidin-5-amine(Non-covalent)

EJR.4: 11 residues within 4Å: Chain A: F.22, N.71, Y.73, N.119, K.136, L.165, D.235, Y.290, M.291, R.292, R.339 15 PLIP interactions: 15 interactions with chain A Hydrophobic interactions: A:Y.73, A:Y.290, A:Y.290, A:R.292 Hydrogen bonds: A:N.119, A:K.136 pi-Stacking: A:F.22, A:F.22, A:Y.73, A:Y.73, A:Y.290, A:Y.290, A:Y.290 pi-Cation interactions: A:R.292, A:R.292

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Huang, Y. et al., Discovery of the Clinical Candidate MAK683: An EED-Directed, Allosteric, and Selective PRC2 Inhibitor for the Treatment of Advanced Malignancies. J.Med.Chem. (2022)

Release Date

2022-04-13

Peptides

Polycomb protein EED: A
Histone-lysine N-methyltransferase EZH2: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Polycomb protein EED

Histone-lysine N-methyltransferase EZH2

Related Entries With Identical Sequence